// App-Quantinova.ai

AEP784 : Polycystic ovary syndrome is burdened with a high comorbidity rate and medication use independent of BMI: A longitudinal community based study

Researchers

Presenter

  • Linda Kujanp

Principal Investigators

  • Terhi Piltonen

  • Riikka Arffman

  • Paula Pesonen

  • Laure Morin-Papunen

  • Juha Tapanainen

  • Stephen Franks

  • Marjo-Riitta Jrvelin

Medical Centers

  • University of Oulu, Oulu, Finland

  • Turku University Hospital, Turku, Finland

  • PEDEGO Research Unit, Oulu, Finland

  • Medical Research Center Oulu, Oulu, Finland

  • Department of Obstetrics and Gynecology and...

  • Infrastructure for Population Studies

  • University of Helsinki, H, Finland

  • Helsinki University Hospital, Helsinki, Finland

  • Imperial College, London, UK

  • Imperial College, Institute of Reproductive and Developmental Biology, London, United Kingdom

  • Center for Life Course Epidemiology, London, United Kingdom

Locations

  • Finland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Polycystic Ovary Syndrome

  • Type 2 diabetes mellitus

  • Chronic obstructive pulmonary disease

  • Diabetes

  • Hyperthyroidism

  • Hypothyroidism

  • Endometriosis

  • Preeclampsia

  • Hypertension

  • Fibromyalgia

  • Tuberculosis

  • Depression

  • Migraine

  • Solid malignancies

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved